Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody

PLoS Pathogens

Volumn 9, Issue 10, 2013, Pages

  Xu, Kai ^a   Rockx, Barry ^b   Xie, Yihu ^a   DeBuysscher, Blair L ^c,d   Fusco, Deborah L ^e   Zhu, Zhongyu ^c   Chan, Yee Peng ^e   Xu, Yan ^a   Luu, Truong ^f,g   Cer, Regina Z ^f,g   Feldmann, Heinz ^c,h   Mokashi, Vishwesh ^f   Dimitrov, Dimiter S ^c   Bishop Lilly, Kimberly A ^f,g   Broder, Christopher C ^e   Nikolov, Dimitar B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF MONTANA   (United States)

^e UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^f NAVAL MEDICAL RESEARCH CENTER   (United States)

^g HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^h UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; EPHRIN B2; G ENVELOPE GLYCOPROTEIN; GLYCOPROTEIN; HUMAN MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; CRYSTALLIZATION; GEL PERMEATION CHROMATOGRAPHY; HENDRA VIRUS; HUMAN; NIPAH VIRUS; NONHUMAN; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; VIROGENESIS; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS MUTANT; VIRUS NEUTRALIZATION;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; CROSS REACTIONS; CRYSTALLOGRAPHY, X-RAY; HENDRA VIRUS; HENIPAVIRUS INFECTIONS; HUMANS; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; VIRAL FUSION PROTEINS;

EID: 84887301850     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003684     Document Type: Article

References (42)

1. Eaton BT, Broder CC, Middleton D, Wang LF, (2006) Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol 4: 23-35.
2. Eaton BT, Mackenzie JS, Wang L-F (2007) Henipaviruses. In: Knipe DM, Howley PM, editors. Fields Virology. 5 ed. Philadelphia: Lippincott Williams & Wilkins. pp. 1587-1600.
3. Field H, Young P, Yob JM, Mills J, Hall L, et al. (2001) The natural history of Hendra and Nipah viruses. Microbes Infect 3: 307-314.
4. Selvey LA, Wells RM, McCormack JG, Ansford AJ, Murray K, et al. (1995) Infection of humans and horses by a newly described morbillivirus. Med J Aust 162: 642-645.
5. Playford EG, McCall B, Smith G, Slinko V, Allen G, et al. (2010) Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008. Emerg Infect Dis 16: 219-223.
6. Wong KT, Robertson T, Ong BB, Chong JW, Yaiw KC, et al. (2009) Human Hendra virus infection causes acute and relapsing encephalitis. Neuropathol Appl Neurobiol 35: 296-305.
7. Bishop KA, Broder CC (2008) Hendra and Nipah: Lethal Zoonotic Paramyxoviruses. In: Scheld WM, Hammer SM, Hughes JM, editors. Emerging Infections. Washington, D.C.: American Society for Microbiology. pp. 155-187.
8. Pallister J, Middleton D, Broder CC, Wang LF, (2011) Henipavirus Vaccine Development. J Bioterr Biodef pp. S1.
9. Xu K, Chan YP, Rajashankar KR, Khetawat D, Yan L, et al. (2012) New insights into the hendra virus attachment and entry process from structures of the virus g glycoprotein and its complex with ephrin-b2. PLoS One 7: e48742.
10. Homaira N, Rahman M, Hossain MJ, Epstein JH, Sultana R, et al. (2010) Nipah virus outbreak with person-to-person transmission in a district of Bangladesh, 2007. Epidemiol Infect 138: 1630-1636.
11. Rahman MA, Hossain MJ, Sultana S, Homaira N, Khan SU, et al. (2011) Date Palm Sap Linked to Nipah Virus Outbreak in Bangladesh, 2008. Vector Borne Zoonotic Dis 12: 65-72.
12. Gurley ES, Montgomery JM, Hossain MJ, Bell M, Azad AK, et al. (2007) Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis 13: 1031-1037.
13. Luby SP, Hossain MJ, Gurley ES, Ahmed BN, Banu S, et al. (2009) Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007. Emerg Infect Dis 15: 1229-1235.
14. Anonymous (2012) Nipah encephalitis, human- Bangladesh: (Jipurhat). International Society for Infectious Diseases archive no. 20120212.1040138 20120212.1040138.
15. Lee B, Ataman ZA, (2011) Modes of paramyxovirus fusion: a Henipavirus perspective. Trends Microbiol 19: 389-399.
16. Dutch RE, (2010) Entry and Fusion of Emerging Paramyxoviruses. PLoS Pathog 6: e1000881.
17. Steffen DL, Xu K, Nikolov DB, Broder CC, (2012) Henipavirus mediated membrane fusion, virus entry and targeted therapeutics. Viruses 4: 280-308.
18. Zhu Z, Dimitrov AS, Bossart KN, Crameri G, Bishop KA, et al. (2006) Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies. J Virol 80: 891-899.
19. Zhu Z, Bossart KN, Bishop KA, Crameri G, Dimitrov AS, et al. (2008) Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. J Infect Dis 197: 846-853.
20. Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, et al. (2009) A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection. PLoS Pathog 5: e1000642.
21. Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, et al. (2011) A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge. Sci Transl Med 3: 105ra103.
22. Rockx B, Bossart KN, Feldmann F, Geisbert JB, Hickey AC, et al. (2010) A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment. J Virol 84: 9831-9839.
23. Xu K, Rajashankar KR, Chan YP, Himanen JP, Broder CC, et al. (2008) Host cell recognition by the henipaviruses: Crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proc Natl Acad Sci U S A 105: 9953-8.
24. Ekiert DC, Kashyap AK, Steel J, Rubrum A, Bhabha G, et al. (2012) Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489: 526-532.
25. Julien JP, Lee PS, Wilson IA, (2012) Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA. Immunol Rev 250: 180-198.
26. Kwong PD, Mascola JR, (2012) Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies. Immunity 37: 412-425.
27. Hwang WC, Lin Y, Santelli E, Sui J, Jaroszewski L, et al. (2006) Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R. J Biol Chem 281: 34610-34616.
28. Prabakaran P, Gan J, Feng Y, Zhu Z, Choudhry V, et al. (2006) Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody. J Biol Chem 281: 15829-15836.
29. Whittle JR, Zhang R, Khurana S, King LR, Manischewitz J, et al. (2011) Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A 108: 14216-14221.
30. Changela A, Wu X, Yang Y, Zhang B, Zhu J, et al. (2011) Crystal structure of human antibody 2909 reveals conserved features of quaternary structure-specific antibodies that potently neutralize HIV-1. J Virol 85: 2524-2535.
31. Pancera M, McLellan JS, Wu X, Zhu J, Changela A, et al. (2010) Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1. J Virol 84: 8098-8110.
32. Pejchal R, Walker LM, Stanfield RL, Phogat SK, Koff WC, et al. (2010) Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1. Proc Natl Acad Sci U S A 107: 11483-11488.
33. Broder CC (2010) Therapeutics and Vaccines against Hendra and Nipah Viruses. In: Levine MM, Dougan G, Good MF, Liu MA, Nabel GJ, Nataro JP, Rappuoli R, editors. New Generation Vaccines. New York: Informa Healthcare USA. pp. 885-894.
34. Broder CC, (2012) Henipavirus outbreaks to antivirals: the current status of potential therapeutics. Curr Opin Virol 2: 176-187.
35. Anonymous (2010) Hendra virus, equine- Australia (04): (Queensland) human exposure. International Society for Infectious Diseases archive no. 20100522.1724 20100522.1724.
36. Bowden TA, Aricescu AR, Gilbert RJ, Grimes JM, Jones EY, et al. (2008) Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. Nat Struct Mol Biol 15: 567-572.
37. Bowden TA, Crispin M, Harvey DJ, Aricescu AR, Grimes JM, et al. (2008) Crystal Structure and Carbohydrate Analysis of Nipah Virus Attachment Glycoprotein: A Template for Antiviral and Vaccine Design. J Virol 82: 11628-11636.
38. Bowden TA, Crispin M, Harvey DJ, Jones EY, Stuart DI, (2010) Dimeric architecture of the Hendra virus attachment glycoprotein: evidence for a conserved mode of assembly. J Virol 84: 6208-6217.
39. Frogel MP, Stewart DL, Hoopes M, Fernandes AW, Mahadevia PJ, (2010) A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis. J Manag Care Pharm 16: 46-58.
40. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40: 658-674.
41. Emsley P, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132.
42. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213-221.